Medical device maker Microtransponder has rolled out a $ 53 million Series e-funding round led by U.S. Venture Partners.
The growth also included participation from GPG Ventures, Accelerator Hunt Ventures, Osage University Partners, Action Potential Venture Capital and Vertical Group. The company said it would use the capital to commercialize its Vivistim Vegas Nerve Stimulation System, an implantable device aimed at improving hand and arm mobility in stroke patients.
“Our investors are inspired by the micro-transponder approach to treating millions of stroke survivors for moderate to severe obstruction. Can help you get back to work, hobbies and experiences of their choice, ”the CEO and director said Richard Faust Said in a statement.
Oma Fertility emerged from Stealth last week with 37.5 million, including $ 29 million in equity and another $ 8.5 million in debt financing.
The Seed and Series A round was led by JAZZ Venture Partners, Root Ventures, Mithril Capital, Global Asset Capital and Free Solo Ventures. The loan facility came from Silicon Valley Bank. The first product of the Fertility Startup aims to identify healthy sperm to improve IVF results.
“Oma Fertility is capitalizing on the opportunity to make technological advances in fertility to meet the growing demand for infertility rates,” co-founder and CEO Gurjit Singh said in a statement. “Our goal is to improve outcomes for more families facing reproductive problems and we strive to create a place where everyone has access to the most advanced, successful fertility treatment for their child.”
Pair-centric healthcare data startup Abacus Insights has raised সি 28 million in Series C funding, bringing its total growth to $ 81 million.
The round was led by Multiplan Corporation with the participation of Blue Venture Fund, CRV, .406 Ventures, Horizon Healthcare Services Inc. and Eco Health Ventures. Raised abacus B 35 million in Series B funding in 2020.
It plans to use the investment to grow its business, improve its platform and recruit more staff.
“This new funding legitimizes our company’s goal of helping health plans release health data,” CEO and founder Dr. Minal Patel said in a statement. “Doing so empowers consumers to make better health choices and empowers physicians to make more informed treatment decisions. Pairs use platforms to enhance their business skills that reduce costs for their members. We are proud to partner with Multiplan because of their leadership position. Serves almost every provider in the country. “
Self-Pay Healthcare Marketplace has raised $ 27 million in a Series B round led by Sesame GV.
Virgin Group, Telesoft Partners, FMZ Ventures, General Catalyst, Industry Ventures, Co-operative Capital, Giant Ventures and Alumni Ventures Group also participated in the launch. Sesame plans to use the capital to raise startups and launch its beta subscription program.
“Sesame provides more access to healthcare to a significant percentage of the population, and we are inspired by the company’s mission to deliver better patient outcomes for underdeveloped communities,” said Kathy Friedman, GV’s executive enterprise partner, in a statement.
“Sesame offers an exciting opportunity to develop a dynamic marketplace on any scale in the current US healthcare ecosystem. We are thrilled to partner with David Goldhill and the entire Sesame team as they move forward.”